Related Experiment Videos
[Central anticholinergic syndrome during postoperative period]
1Anaesthesia Pharmacology Research School of Medicine, Erasmus University, Rotterdam, Netherlands.
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1990
Summary
Central anticholinergic syndrome (CAS) presents with central and peripheral signs, often triggered by medications. Diagnosis relies on excluding other conditions and response to physostigmine.
Area of Science:
- Anesthesiology
- Pharmacology
- Neurology
Context:
- Central anticholinergic syndrome (CAS) is a clinical condition characterized by a distinct set of central and peripheral signs.
- It arises from the blockade of central cholinergic sites by specific drugs or reduced acetylcholine release.
- CAS can be induced by various medications, including atropine sulfate, scopolamine, promethazine, benzodiazepines, opioids, and certain anesthetic agents.
Purpose:
- To describe the clinical presentation, causes, incidence, differential diagnosis, and diagnostic approach to central anticholinergic syndrome (CAS).
Summary:
- CAS manifests with central symptoms (e.g., confusion, delirium, coma) and peripheral signs (e.g., dry mouth, tachycardia, urinary retention).
- The incidence of CAS postoperatively varies, with higher rates following general anesthesia compared to regional anesthesia with sedation.
- Differential diagnosis is extensive, encompassing drug toxicity, metabolic disturbances, and neurological events, often leading to a diagnosis of exclusion confirmed by physostigmine response.
Impact:
- Understanding CAS is crucial for accurate diagnosis and management in postoperative patients.
- Prompt recognition and treatment can prevent complications associated with anticholinergic toxicity.
- This knowledge aids clinicians in differentiating CAS from other conditions, optimizing patient care.